Far Eastern Memorial Hospital
S Heng-M Ou H dies
Our preliminary analysis with clinical database suggested that, in patients with type I endometrial cancer, high ketohexokinase-expressing group have lower survival probabilities than low ketohexokinase-expressing group. To understand the importance of ketohexokinase expression and isoform switch during the development of type I endometrial cancer, we propose a series of in vitro experiments and clinical examinations in this project.
Endometrial Cancer
ketohexokinase
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 220 participants |
| Official Title : | Prognostic Evaluations of Ketohexokinase Isoforms in Endometrial Cancer |
| Actual Study Start Date : | 2019-04-11 |
| Estimated Primary Completion Date : | 2024-12-31 |
| Estimated Study Completion Date : | 2024-12-31 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 20 Years |
| Sexes Eligible for Study: | FEMALE |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital
B Anqiao, New Taipei, Taiwan, 22050